The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases
Open accessAbstract
Probiotics and synbiotics are used to treat chronic diseases, principally due to their role in immune system modulation and the anti-inflammatory response. The present study reviewed the effects of probiotics and synbiotics on intestinal chronic diseases in in vitro, animal, and human studies, particularly in randomized clinical trials. The selected probiotics exhibit in vitro anti-inflammatory properties. Probiotic strains and cell-free supernatants reduced the expression of pro-inflammatory cytokines via action that is principally mediated by toll-like receptors. Probiotic administration improved the clinical symptoms, histological alterations, and mucus production in most of the evaluated animal studies, but some results suggest that caution should be taken when administering these agents in the relapse stages of IBD. In addition, no effects on chronic enteropathies were reported. Probiotic supplementation appears to be potentially well tolerated, effective, and safe in patients with IBD, in both CD and UC. Indeed, probiotics such as Bifidobacterium longum 536 improved the clinical symptoms in patients with mild to moderate active UC. Although it has been proposed that probiotics can provide benefits in certain conditions, the risks and benefits should be carefully assessed before initiating any therapy in patients with IBD. For this reason, further studies are required to understand the precise mechanism by which probiotics and synbiotics affect these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,667
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,159
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276 · cited 2×
“, 2017 have reported that intensive-dosing, multidonor FMT induces clinical remission and endoscopic improvement in active UC and is associated with distinct microbial changes that relate to the outcome [67].”
BackgroundProbiotic Mechanisms of Action
Bermudez-Brito, M., Plaza-Díaz, J., Muñoz-Quezada, S., Gómez-Llorente, C., & Gil, A. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000342079 · Cited by 1,234
Self-citationProbiotics: an overview of beneficial effects
Ouwehand, A. C., Salminen, S., & Isolauri, E. (2002) · Antonie van Leeuwenhoek · doi:10.1023/a:1020620607611 · Cited by 1,013
The Prolongation of Life: Optimistic Studies
Metchnikoff, É. (2003) · Cited by 874
Prebiotics and probiotics: are they functional foods?
Roberfroid, M. B. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1682s · Cited by 731
Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis
Tojo, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15163 · Cited by 533
Bifidobacterium infantis35624 modulates host inflammatory processes beyond the gut
Groeger, D., O’Mahony, L., Murphy, E. F., Bourke, J. F., Dinan, T. G., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2013) · Gut Microbes · doi:10.4161/gmic.25487 · Cited by 448 · cited 2×
“, 2013 [76] 22 UC patients, 48 patients with chronic fatigue syndrome and 26 psoriasis patients B.”
BackgroundFAO Technical Meeting on Prebiotics
Pineiro, M., Asp, N.-G., Reid, G., Macfarlane, S., Morelli, L., Brunser, O., & Tuohy, K. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31817f184e · Cited by 399
Butyricicoccus pullicaecorum in inflammatory bowel disease
Eeckhaut, V., Machiels, K., Perrier, C., Romero, C., Maes, S., Flahou, B., Steppe, M., Haesebrouck, F., Sas, B., Ducatelle, R., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303611 · Cited by 369
Sources, isolation, characterisation and evaluation of probiotics
Fontana, L., Bermudez-Brito, M., Plaza-Diaz, J., Muñoz-Quezada, S., & Gil, A. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512004011 · Cited by 348
Sáez-Lara, M., Robles-Sanchez, C., Ruiz-Ojeda, F., Plaza-Diaz, J., & Gil, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060928 · Cited by 328
Self-citationMicroscopic colitis: Current status, present and future challenges
Münch, A., Aust, D., Bohr, J., Bonderup, O., Fernández Bañares, F., Hjortswang, H., Madisch, A., Munck, L. K., Ström, M., Tysk, C., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.05.014 · Cited by 259
The Impact of Probiotic on Gut Health
Collado, M., Isolauri, E., Salminen, S., & Sanz, Y. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048437 · Cited by 244
Fedorak, R. N., Feagan, B. G., Hotte, N., Leddin, D., Dieleman, L. A., Petrunia, D. M., Enns, R., Bitton, A., Chiba, N., Paré, P., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.031 · Cited by 229
Tamaki, H., Nakase, H., Inoue, S., Kawanami, C., Itani, T., Ohana, M., Kusaka, T., Uose, S., Hisatsune, H., Tojo, M., et al. (2016) · Digestive Endoscopy · doi:10.1111/den.12553 · Cited by 214
Probiotic Bacteria Influence the Composition and Function of the Intestinal Microbiota
O'Toole, P. W., & Cooney, J. C. (2008) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2008/175285 · Cited by 198
Saccharomyces boulardii Does Not Prevent Relapse of Crohn's Disease
Bourreille, A., Cadiot, G., Le Dreau, G., Laharie, D., Beaugerie, L., Dupas, J., Marteau, P., Rampal, P., Moyse, D., Saleh, A., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.021 · Cited by 186
Wedlake, L., Slack, N., Andreyev, H. J. N., & Whelan, K. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437984.92565.31 · Cited by 160
Role of Toll-like receptors in the development of immunotolerance mediated by probiotics
Gómez-Llorente, C., Muñoz, S., & Gil, A. (2010) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110001527 · Cited by 160
Self-citationVahabnezhad, E., Mochon, A. B., Wozniak, L. J., & Ziring, D. A. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318279abf0 · Cited by 156
Dai, C., Zheng, C., Meng, F., Zhou, Z., Sang, L.-X., & Jiang, M. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1488-3 · Cited by 156
Vitamin D receptor pathway is required for probiotic protection in colitis
Wu, S., Yoon, S. S., Zhang, Y., Lu, R., Xia, Y., Wan, J., Petrof, E. O., Claud, E. C., Chen, D., & Sun, J. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00105.2015 · Cited by 142
Wu, Y., Zhu, C., Chen, Z., Chen, Z., Zhang, W., Ma, X., Wang, L., Yang, X., & Jiang, Z. (2016) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2016.03.005 · Cited by 142
Yoshimatsu, Y., Yamada, A., Furukawa, R., Sono, K., Osamura, A., Nakamura, K., Aoki, H., Tsuda, Y., Hosoe, N., Takada, N., et al. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i19.5985 · Cited by 138
Petersen, A. M., Mirsepasi‐Lauridsen, H. C., Halkjær, S. I., Mortensen, E. M., Nordgaard-Lassen, I., & Krogfelt, K. A. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.06.001 · Cited by 136
Probiotics and prebiotics in ulcerative colitis
Derikx, L. A. A. P., Dieleman, L. A., & Hoentjen, F. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.005 · Cited by 128
Bermúdez-Brito, M., Muñoz‐Quezada, S., Gómez‐Llorente, C., Matencio, E., Bernal, M. J., Romero, F., & Gil, Á. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059370 · Cited by 117
Some insights into the derivation and early uses of the word ‘probiotic’
Hamilton-Miller, J. M. T., Gibson, G. R., & Brück, W. M. (2003) · British Journal Of Nutrition · doi:10.1079/bjn2003954 · Cited by 115
Meini, S., Laureano, R., Fani, L., Tascini, C., Galano, A., Antonelli, A., & Rossolini, G. M. (2015) · Infection · doi:10.1007/s15010-015-0798-2 · Cited by 106
de LeBlanc, A. D. M., & LeBlanc, J. G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16518 · Cited by 104
Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis
Suskind, D. L., Singh, N., Nielson, H., & Wahbeh, G. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000544 · Cited by 99
Lactobacillus rhamnosus bacteremia: An emerging clinical entity
Gouriet, F., Million, M., Henri, M., Fournier, P.-E., & Raoult, D. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1599-5 · Cited by 93
Wachi, S., Kanmani, P., Tomosada, Y., Kobayashi, H., Yuri, T., Egusa, S., Shimazu, T., Suda, Y., Aso, H., Sugawara, M., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400218 · Cited by 89
Modulation of dendritic cell phenotype and functionin an in vitro model of the intestinal epithelium
Butler, M., Ng, C., van Heel, D. A., Lombardi, G., Lechler, R. I., Playford, R. J., & Ghosh, S. K. (2006) · European Journal of Immunology · doi:10.1002/eji.200535497 · Cited by 85
Bermúdez-Brito, M., Muñoz‐Quezada, S., Gómez‐Llorente, C., Matencio, E., Bernal, M. J., Romero, F., & Gil, Á. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043197 · Cited by 85
Plaza‐Díaz, J., Gómez‐Llorente, C., Abadía‐Molina, F., Sáez‐Lara, M. J., Campaña‐Martín, L., Muñoz‐Quezada, S., Romero, F., Gil, Á., & Fontana, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098401 · Cited by 84
Self-citation1H NMR-based metabonomic assessment of probiotic effects in a colitis mouse model
Hong, Y., Ahn, Y., Park, J.-C., Lee, J.-H., Lee, H., Huh, C., Kim, D., Ryu, D. H., & Hwang, G. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-0716-1 · Cited by 80
Persborn, M., Gerritsen, J., Wallon, C., Carlsson, A. H., Akkermans, L. M. A., & Söderholm, J. D. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12451 · Cited by 79
Alterations in the Intestinal Microbiota and Functional Bowel Symptoms
Ringel, Y., & Carroll, I. M. (2009) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2008.12.004 · Cited by 73 · cited 1×
“Data from clinical trials indicate that certain intestinal disease conditions, including NEC, pouchitis, UC, and irritable bowel syndrome (IBS), have yielded clinical benefits with some probiotic and synbiotic interventions [29], because probiotics largely act directly or indirectly on the intestinal microbiota [30].”
BackgroundMann, E. R., Bernardo, D., Ng, S. C., Rigby, R. J., Al-Hassi, H. O., Landy, J., Peake, S. T. C., Spranger, H., English, N. R., Thomas, L. V., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000223 · Cited by 73
Garrido‐Mesa, N., Utrilla, P., Comalada, M., Zorrilla, P., Garrido‐Mesa, J., Zarzuelo, A., Rodríguez‐Cabezas, M. E., & Gálvez, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.09.004 · Cited by 73
Inhibition of Chronic Ulcerative Colitis-associated Adenocarcinoma Development in Mice by VSL#3
Talero, E., Bolívar, S., Ávila‐Román, J., Alcaide, A. M., Fiorucci, S., & Motilva, V. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000346 · Cited by 69
Toumi, R., Abdelouhab, K., Rafa, H., Soufli, I., Raissi-Kerboua, D., Djeraba, Z., & Touil-Boukoffa, C. (2013) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2013.790413 · Cited by 68
Protective effects of cathelicidin‐encoding Lactococcus lactis in murine ulcerative colitis
Wong, C. C. M., Zhang, L., Li, Z. J., Wu, W. K. K., Ren, S. X., Chen, Y., Ng, T. B., & Cho, C. H. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07158.x · Cited by 65
Plaza‐Díaz, J., Fernández-Caballero, J. Á., Chueca, N., García, F., Gómez‐Llorente, C., Sáez‐Lara, M. J., Fontana, L., & Gil, Á. (2015) · Nutrients · doi:10.3390/nu7063999 · Cited by 62
Self-citationGiahi, L., Aumueller, E., Elmadfa, I., & Haslberger, A. G. (2012) · Beneficial Microbes · doi:10.3920/bm2011.0052 · Cited by 61
Bermúdez-Brito, M., Muñoz‐Quezada, S., Gómez‐Llorente, C., Romero, F., & Gil, Á. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114513004303 · Cited by 60
Kumar, C. S. V. S., Reddy, K. K., Reddy, A. G., Vinoth, A., Chowdary, S. R., Gopu, B., & Rao, G. S. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.02.026 · Cited by 59
Zhang, H., Li, W.-S., Xu, D.-N., Zheng, W., Liu, Y., Chen, J., Qiu, Z.-B., Dorfman, R. G., Zhang, J., & Liu, J. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3686 · Cited by 55
Schmitz, S. S., Werling, D., & Allenspach, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120779 · Cited by 54
Plaza‐Díaz, J., Robles-Sánchez, C., Abadía‐Molina, F., Morón-Calvente, V., Sáez‐Lara, M. J., Ruiz‐Bravo, A., Jiménez‐Valera, M., Gil, Á., Gómez‐Llorente, C., & Fontana, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-02203-3 · Cited by 51
Self-citationPrisciandaro, L. D., Geier, M. S., Chua, A., Butler, R. N., Cummins, A. G., Sander, G. R., & Howarth, G. S. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1446-3 · Cited by 45
Plaza-Diaz, J., Gomez-Llorente, C., Campaña-Martin, L., Matencio, E., Ortuño, I., Martínez-Silla, R., Gomez-Gallego, C., Periago, M. J., Ros, G., Chenoll, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078111 · Cited by 44
Abdelouhab, K., Rafa, H., Toumi, R., Bouaziz, S., Medjeber, O., & Touil–Boukoffa, C. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2011.641971 · Cited by 43
Ahmed, J., Reddy, B. S., Mølbak, L., Leser, T. D., & MacFie, J. (2013) · International Journal of Surgery · doi:10.1016/j.ijsu.2013.08.019 · Cited by 41
Cui, Y., Wei, H., Lu, F., Liu, X., Liu, D., Gu, L., & Ouyang, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148241 · Cited by 40
Štofilová, J., Szabadosova, V., Hrčková, G., Salaj, R., Bertková, I., Hijová, E., Strojný, L., & Bomba, A. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.12.022 · Cited by 33
Hevia, A., López, P., Suárez, A., Jacquot, C., Urdaci, M. C., Margollés, A., & Sánchez, B. (2014) · BioMed Research International · doi:10.1155/2014/351204 · Cited by 31
VSL#3 probiotics provide protection against acute intestinal ischaemia/reperfusion injury
Salim, S. Y., Young, P. Y., Lukowski, C. M., Madsen, K. L., Sis, B., Churchill, T. A., & Khadaroo, R. G. (2013) · Beneficial Microbes · doi:10.3920/bm2013.0026 · Cited by 27
Mann, E. R., You, J., der Sluis, V. H.-V., Bernardo, D., Al-Hassi, H. O., Landy, J., Peake, S. T. C., Thomas, L. V., Tee, D., Lee, G. H., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/573576 · Cited by 25
Brace, C., Gloor, G. B., Ropeleski, M. J., Allen‐Vercoe, E., & Petrof, E. O. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.01.020 · Cited by 23
Zheng, B., van Bergenhenegouwen, J., van de Kant, H. J. G., Folkerts, G., Garssen, J., Vos, A. P., Morgan, M. E., & Kraneveld, A. D. (2015) · Beneficial Microbes · doi:10.3920/bm2015.0037 · Cited by 23
Profermin is Efficacious in Patients with Active Ulcerative Colitis—A Randomized Controlled Trial
Krag, A. A., Munkholm, P., Israelsen, H., von Ryberg, B., Andersen, K. K., & Bendtsen, F. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437046.26036.db · Cited by 21
Study on the effects of microencapsulatedLactobacillus delbrueckiion the mouse intestinal flora
Sun, Q., Shi, Y., Wang, F., Han, D., Hong, L., Zhao, Y., & Sun, Q. (2015) · Journal of Microencapsulation · doi:10.3109/02652048.2015.1057249 · Cited by 16
Yang, X., Fu, Y., Liu, J., & Ren, H. (2013) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-013-1177-9 · Cited by 12
Cited by
Human gut microbiota/microbiome in health and diseases: a review
Gomaa, E. Z. (2020) · Antonie van Leeuwenhoek · doi:10.1007/s10482-020-01474-7 · Cited by 1,294
Gut Microbiome: Profound Implications for Diet and Disease
Hills, R., Pontefract, B., Mishcon, H., Black, C., Sutton, S., & Theberge, C. (2019) · Nutrients · doi:10.3390/nu11071613 · Cited by 1,092
Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Kowalski, K., & Mulak, A. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18087 · Cited by 826
Crucian, B. E., Choukèr, A., Simpson, R. J., Mehta, S., Marshall, G., Smith, S. M., Zwart, S. R., Heer, M., Ponomarev, S., Whitmire, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01437 · Cited by 421
Gut-brain Axis and migraine headache: a comprehensive review
On behalf of the School of Advanced Studies of the European Headache Federation (EHF-SAS), Arzani, M., Jahromi, S. R., Ghorbani, Z., Vahabizad, F., Martelletti, P., Ghaemi, A., Sacco, S., & Togha, M. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-1078-9 · Cited by 366
Metadata
- Authors
- Plaza-Díaz, J., Ruiz-Ojeda, F., Vilchez-Padial, L., & Gil, A.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2017-05-28
- Volume
- 9
- Issue
- 6
- Pages
- 555
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2617897352
- Cited by
- 423
- References
- 72
- FWCI
- 34.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.